| scholarly article | Q13442814 |
| P2093 | author name string | Olivier Thaunat | |
| P2860 | cites work | Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies | Q84581805 |
| De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure | Q84752864 | ||
| Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates | Q30090232 | ||
| In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy | Q31920320 | ||
| Immune responses elicited in tertiary lymphoid tissues display distinctive features | Q33627619 | ||
| Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans | Q33882838 | ||
| Identification of a B cell signature associated with renal transplant tolerance in humans. | Q33882845 | ||
| High levels of catalytic antibodies correlate with favorable outcome in sepsis. | Q33932633 | ||
| Catalytic antibodies | Q34050745 | ||
| Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response | Q34078561 | ||
| B-cell-depleting induction therapy and acute cellular rejection | Q34085081 | ||
| CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients | Q34093165 | ||
| B cells regulate autoimmunity by provision of IL-10. | Q34150590 | ||
| Prevention of arthritis by interleukin 10-producing B cells | Q34178104 | ||
| Non-MHC antigenic targets of the humoral immune response in transplantation | Q34259047 | ||
| Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies | Q35026108 | ||
| Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice | Q35655757 | ||
| Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening | Q36351776 | ||
| Is defective lymphatic drainage a trigger for lymphoid neogenesis? | Q36571605 | ||
| The impact of glycosylation on the biological function and structure of human immunoglobulins. | Q36618276 | ||
| Open conformers: the hidden face of MHC-I molecules | Q36721442 | ||
| Accommodation of grafts: implications for health and disease | Q36902090 | ||
| Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures | Q37132842 | ||
| Terminal sugars of Fc glycans influence antibody effector functions of IgGs | Q37209069 | ||
| Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation | Q37226955 | ||
| Lymphoid neogenesis in chronic rejection | Q37228243 | ||
| HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration | Q37426000 | ||
| Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys | Q37485481 | ||
| Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways | Q37596125 | ||
| Immunologic basis of transplant-associated arteriosclerosis | Q37628358 | ||
| Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis. | Q37719213 | ||
| Transplantation of discordant xenografts: a review of progress | Q37781951 | ||
| Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression | Q38314177 | ||
| Characterization of intra-graft B cells during renal allograft rejection | Q38426194 | ||
| Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal | Q39824383 | ||
| B cells acquire antigen from target cells after synapse formation | Q40803432 | ||
| Characterization, evolution, and molecular basis of a polymorphic antigenic determinant shared by HLA-A and B products | Q42664634 | ||
| Two levels of help for B cell alloantibody production | Q42943353 | ||
| Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patients | Q43675929 | ||
| Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 | ||
| Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. | Q45964495 | ||
| Humoral Antibodies in Renal Allotransplantation in Man | Q47784760 | ||
| Superantibody activities: new players in innate and adaptive immune responses | Q48013116 | ||
| Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. | Q50765005 | ||
| Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. | Q51038604 | ||
| Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. | Q51051161 | ||
| Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. | Q51060341 | ||
| Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis. | Q51143704 | ||
| Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation. | Q51959096 | ||
| A critical role for B cells in the development of memory CD4 cells. | Q52023414 | ||
| Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. | Q53243295 | ||
| Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. | Q53555780 | ||
| Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. | Q53924174 | ||
| Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. | Q54399816 | ||
| Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. | Q54469292 | ||
| B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. | Q54528998 | ||
| Chronic Rejection Triggers the Development of an Aggressive Intragraft Immune Response through Recapitulation of Lymphoid Organogenesis | Q59387561 | ||
| Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts | Q62513513 | ||
| Feedback suppression of the immune response in vivo. I. Immune B cells induce antigen-specific suppressor T cells | Q72755744 | ||
| Capillary deposition of C4d complement fragment and early renal graft loss | Q72791721 | ||
| Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum | Q73330662 | ||
| Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction | Q73775374 | ||
| Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue | Q73844688 | ||
| Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice | Q73987284 | ||
| Involvement of antibody-dependent apoptosis in graft rejection | Q74052979 | ||
| Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants | Q74500042 | ||
| Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection | Q74644326 | ||
| Heme oxygenase: protective gene or Trojan horse | Q77658667 | ||
| Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates | Q79741123 | ||
| Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection | Q81395004 | ||
| The B-cell response to protein antigens in immunity and transplantation | Q81525404 | ||
| Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy | Q81778125 | ||
| Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels | Q81964906 | ||
| Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients | Q82213207 | ||
| Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection | Q83014796 | ||
| Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA) | Q83101436 | ||
| Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients | Q83149390 | ||
| Pathophysiologic significance of B-cell clusters in chronically rejected grafts | Q84069737 | ||
| Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection | Q84261290 | ||
| Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera | Q84540996 | ||
| P433 | issue | 2-3 | |
| P304 | page(s) | 101-106 | |
| P577 | publication date | 2011-11-12 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Humoral immunity in chronic allograft rejection: puzzle pieces come together | |
| P478 | volume | 26 |
| Q51682057 | Anti-Donor HLA Antibody Response After Pancreatic Islet Grafting: Characteristics, Risk Factors, and Impact on Graft Function. |
| Q35117594 | Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats |
| Q50531944 | CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression. |
| Q27013040 | Cell therapy to induce allograft tolerance: time to switch to plan B? |
| Q40861983 | Cellular immune profile of kidney transplant patients developing anti-HLA antibodies during childhood |
| Q53229165 | Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys. |
| Q36663036 | Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance |
| Q35027253 | Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. |
| Q53536908 | Face Transplantation: Partial Graft Loss of the First Case 10 Years Later. |
| Q36514875 | HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients |
| Q64069939 | Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes |
| Q34962680 | IVIg treatment reduces catalytic antibody titers of renal transplanted patients |
| Q35658358 | Immunogenicity of infectious pathogens and vaccine antigens |
| Q43700035 | Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival. |
| Q38418186 | Monitoring B cell subsets and alloreactivity in kidney transplantation. |
| Q56978416 | Mortality after steroid-resistant acute cellular rejection and chronic rejection episodes in adult intestinal transplants: report from a single center in induction/preconditioning era |
| Q35659332 | Recent advances in renal transplantation: antibody-mediated rejection takes center stage |
| Q36977339 | Renal ischemia-reperfusion injury amplifies the humoral immune response |
| Q64235794 | Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression |
| Q36238316 | Soothing touch of CD31 protects endothelium during cellular immune responses |
Search more.